NCT05143333 Cognitive Assessment in COVID-19 Positive Patients Using the DANA App Status COMPLETED Phase N/A
NCT05143320 Cognitive, Emotional and Behavioural Impairments in Patients After Sars-Cov2 Infection Status COMPLETED Phase N/A
NCT05142553 Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration. Status COMPLETED Phase PHASE2
NCT05142527 Study to Evaluate the Safety and Efficacy of a Monoclonal Antibody Cocktail for the Prevention of COVID-19 Status WITHDRAWN Phase PHASE2/PHASE3
NCT05142514 Safety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-19, Known as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2) Status COMPLETED Phase PHASE2
NCT05142501 Observation of the Immune Response After COVID-19 Additional Vaccine Doses in Chronic Patients in Hemodialysis Therapy Status TERMINATED Phase N/A
NCT05142488 Study of Immunogenicity Equivalence of a Homologous Third Dose of Covid-19 (Recombinante) Vaccine Status UNKNOWN Phase PHASE4
NCT05142319 Efficacy of Different COVID-19 Vaccine Combinations in Inducing Long-term Humoral Immunity [PRIBIVAC] Status COMPLETED Phase PHASE4
NCT05139927 Using MOST to Optimize an Intervention to Increase COVID-19 Testing for Frontline Essential Workers Status COMPLETED Phase NA
NCT05137418 Safety and Immunogenicity of COVID-19 Vaccine, Inactivated in Healthy Population Aged From 3 to 11 Years Status COMPLETED Phase PHASE3
NCT05135546 Inhaled Recombinant Non-immunogenic Staphylokinase vs Placebo in Patients With COVID-19 - FORRIF Trial Status TERMINATED Phase PHASE2/PHASE3
NCT05133622 Physical Fitness in Young Healthy Adults After COVID-19 Infection Status COMPLETED Phase NA
NCT05132855 The Immune Response of Heterologous Boost Third Dose of mRNA and Protein COVID-19 Vaccine Status UNKNOWN Phase PHASE1/PHASE2
NCT05131594 Evaluating the Response of the Immune System of People with Long COVID (post SARS-CoV-2) Status ENROLLING_BY_INVITATION Phase N/A